Association between coronary microvascular function and the vasa vasorum in patients with early coronary artery disease

Atherosclerosis

Volumn 253, Issue , 2016, Pages 144-149

  Park, Kyoung Ha ^a,b   Sun, Tao ^a   Diez Delhoyo, Felipe ^a   Liu, Zhi ^a   Yang, Shi Wei ^a   Lennon, Ryan J ^a   Herrmann, Joerg ^a   Gulati, Rajiv ^a   Rodriguez Porcel, Martin ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b Hallym University Medical Center   (South Korea)

Author keywords

Microvascular function; Optical coherence tomography; Vasa vasorum

Indexed keywords

ACETYLCHOLINE; ADENOSINE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DENSITY; DOPPLER ULTRASONOGRAPHY; FEMALE; FRAMINGHAM RISK SCORE; FUNCTION TEST; GUIDE WIRE; HEART CATHETERIZATION; HUMAN; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROCIRCULATION; MICROVASCULATURE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; VASA VASORUM; ADVENTITIA; AGED; ATHEROSCLEROSIS; BLOOD; BLOOD FLOW VELOCITY; CORONARY BLOOD VESSEL; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADVENTITIA; AGED; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; VASA VASORUM;

EID: 84986266791     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.08.031     Document Type: Article

References (35)

1. [1] Rubinshtein, R., Yang, E.H., Rihal, C.S., Prasad, A., Lennon, R.J., Best, P.J., et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur. Heart J. 31 (2010), 936–942.
2. [2] Taqueti, V.R., Hachamovitch, R., Murthy, V.L., Naya, M., Foster, C.R., Hainer, J., et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131 (2015), 19–27.
3. [3] Suwaidi, J.A., Hamasaki, S., Higano, S.T., Nishimura, R.A., Holmes, D.R. Jr., Lerman, A., Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000), 948–954.
4. [4] Santos-Gallego, C.G., Picatoste, B., Badimon, J.J., Pathophysiology of acute coronary syndrome. Curr. Atheroscler. Rep., 16, 2014, 401.
5. [5] Drexler, H., Zeiher, A.M., Meinzer, K., Just, H., Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338 (1991), 1546–1550.
6. [6] Chan, S.Y., Brunken, R.C., Czernin, J., Porenta, G., Kuhle, W., Krivokapich, J., et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J. Am. Coll. Cardiol. 20 (1992), 979–985.
7. [7] Sara, J.D., Widmer, R.J., Matsuzawa, Y., Lennon, R.J., Lerman, L.O., Lerman, A., Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc. Interv. 8 (2015), 1445–1453.
8. [8] Hasdai, D., Holmes, D.R. Jr., Higano, S.T., Burnett, J.C. Jr., Lerman, A., Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin. Proc. 73 (1998), 1133–1140.
9. [9] Kwon, H.M., Sangiorgi, G., Ritman, E.L., McKenna, C., Holmes, D.R. Jr., Schwartz, R.S., et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J. Clin. Invest. 101 (1998), 1551–1556.
10. [10] Aoki, T., Rodriguez-Porcel, M., Matsuo, Y., Cassar, A., Kwon, T.G., Franchi, F., et al. Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography–animal and human studies. Atherosclerosis 239 (2015), 203–208.
11. [11] Barger, A.C., Beeuwkes, R. 3rd, Lainey, L.L., Silverman, K.J., Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N. Engl. J. Med. 310 (1984), 175–177.
12. [12] Nishimiya, K., Matsumoto, Y., Takahashi, J., Uzuka, H., Odaka, Y., Nihei, T., et al. In vivo visualization of adventitial vasa vasorum of the human coronary artery on optical frequency domain imaging. Validation study. Circ. J. 78 (2014), 2516–2518.
13. [13] Park, K.H., Kwon, T.G., Matsuzawa, Y., Sun, T., Liu, Z., Lennon, R.J., et al. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis. Eur. Heart J. Cardiovasc. Imaging 17 (2016), 272–279.
14. [14] Alfonso, F., De la Torre Hernandez JM. Vasa vasorum and coronary artery disease progression: optical coherence tomography findings. Eur. Heart J. Cardiovasc. Imaging 17 (2016), 280–282.
15. [15] Nishimiya, K., Matsumoto, Y., Takahashi, J., Uzuka, H., Wang, H., Tsuburaya, R., et al. Enhanced adventitial vasa vasorum formation in patients with vasospastic angina: assessment with OFDI. J. Am. Coll. Cardiol. 67 (2016), 598–600.
16. [16] Villines, T.C., Taylor, A.J., Multi-ethnic study of atherosclerosis arterial age versus framingham 10-year or lifetime cardiovascular risk. Am. J. Cardiol. 110 (2012), 1627–1630.
17. [17] Wilson, P.W., D'Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H., Kannel, W.B., Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998), 1837–1847.
18. [18] Pries, A.R., Habazettl, H., Ambrosio, G., Hansen, P.R., Kaski, J.C., Schachinger, V., et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc. Res. 80 (2008), 165–174.
19. [19] Sucato, V., Novo, G., Evola, S., Novo, S., Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome. Int. J. Cardiol. 186 (2015), 96–97.
20. [20] Kaufmann, P.A., Gnecchi-Ruscone, T., di Terlizzi, M., Schafers, K.P., Luscher, T.F., Camici, P.G., Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102 (2000), 1233–1238.
21. [21] Herrmann, J., Lerman, L.O., Rodriguez-Porcel, M., Holmes, D.R. Jr., Richardson, D.M., Ritman, E.L., et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc. Res. 51 (2001), 762–766.
22. [22] O'Brien, K.D., McDonald, T.O., Chait, A., Allen, M.D., Alpers, C.E., Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996), 672–682.
23. [23] Choi, B.J., Matsuo, Y., Aoki, T., Kwon, T.G., Prasad, A., Gulati, R., et al. Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 2473–2477.
24. [24] Taruya, A., Tanaka, A., Nishiguchi, T., Matsuo, Y., Ozaki, Y., Kashiwagi, M., et al. Vasa vasorum restructuring in human atherosclerotic plaque vulnerability: a clinical optical coherence tomography study. J. Am. Coll. Cardiol. 65 (2015), 2469–2477.
25. [25] Nishimiya, K., Matsumoto, Y., Uzuka, H., Ogata, T., Hirano, M., Shindo, T., et al. Beneficial effects of a novel bioabsorbable polymer coating on enhanced coronary vasoconstricting responses after drug-eluting stent implantation in pigs in vivo. JACC Cardiovasc. Interv. 9 (2016), 281–291.
26. [26] Halcox, J.P., Schenke, W.H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M.A., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002), 653–658.
27. [27] Goel, S., Duda, D.G., Xu, L., Munn, L.L., Boucher, Y., Fukumura, D., et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91 (2011), 1071–1121.
28. [28] Yokoyama, I., Momomura, S., Ohtake, T., Yonekura, K., Nishikawa, J., Sasaki, Y., et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 30 (1997), 1472–1477.
29. [29] Baller, D., Notohamiprodjo, G., Gleichmann, U., Holzinger, J., Weise, R., Lehmann, J., Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 99 (1999), 2871–2875.
30. [30] Mulligan-Kehoe, M.J., Simons, M., Vasa vasorum in normal and diseased arteries. Circulation 129 (2014), 2557–2566.
31. [31] Bottcher, M., Botker, H.E., Sonne, H., Nielsen, T.T., Czernin, J., Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X. Circulation 99 (1999), 1795–1801.
32. [32] Cannon, R.O. 3rd, Schenke, W.H., Quyyumi, A., Bonow, R.O., Epstein, S.E., Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina. Circulation 83 (1991), III77–81.
33. [33] Wilson, R.F., Wyche, K., Christensen, B.V., Zimmer, S., Laxson, D.D., Effects of adenosine on human coronary arterial circulation. Circulation 82 (1990), 1595–1606.
34. [34] Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Flore V et al. Intracoronary adenosine: dose-response relationship with hyperemia. JACC Cardiovasc. Interv.;8:1422–1430.
35. [35] Santos-Gallego, C.G., Giannarelli, C., Badimon, J.J., Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux. Curr. Atheroscler. Rep. 13 (2011), 266–276.